A new paper in the Scandinavian Journal of Urology has provided us with some insights into things associated (and not associated) with risk for a diagnosis of prostate cancer, based on data from > 12,000 participants in the Finnish cohort of the European Randomized Screening for Prostate Cancer (ERSPC) study. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Diagnosis, ibuprofen, mortality, NSAID, onset, puberty, risk, vitamin | 4 Comments »
Data from the VITAL cohort study do not support the use of non-steroidal anti-inflammatory drugs (NSAIDs) in the chemoprevention of prostate cancer, according to a newly published study. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: non-steroidal anti-inflammatory agent, NSAID, prevetion | Leave a comment »
It has been known for a while that statins and nonsteroidal anti-inflammatory drugs (NSAIDs) can affect PSA levels. A new paper now opens the question of whether men who take these and/or other drugs for significant time periods are at risk for a “missed” diagnosis of prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: diuretic, NSAID, PSA, risk, statin | 3 Comments »
Data gathered as part of the ongoing ProtecT study in the United Kingdom provides no evidence that regular use of non-steroidal anti-inflammatory drugs l(NSAIDs) lowers risk for prostate cancer. … READ MORE …
Filed under: Prevention | Tagged: acetaminophen, aspirin, inflammation, NSAID | Leave a comment »
There have been a lot of data published on the potential implications of long-term use of statins (e.g., simvastatin/Zocor and atorvastatin/Lipitor) and non-steroidal antianflammmatory drugs (NSAIDs, e.g., aspirin and ibuprofen) in prevention and management of prostate cancer. But what we are really sure of at the moment is limited. … READ MORE …
Filed under: Living with Prostate Cancer | Tagged: ACM, all cause mortality, NSAID, statin, survival | 3 Comments »
Many papers have previously suggested an association between the long-term use of statins (e.g., simvastatin/Zocor and atorvastatin/Lipitor) or nonsteroidal anti-inflammatory drugs (NSAIDs, like aspirin), the risk of prostate cancer diagnosis, and the overall survival of men diagnosed with prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Prevention, Treatment | Tagged: mortality, NSAID, overall, statin | Leave a comment »
Over the years there have been several studies suggesting that regular use of non-steroidal anti-inflammatory agents (NSAIDs) — the most common being aspirin — can decrease prostate inflammation and prostate cancer risk. Since aspirin and other NSAIDs are commonly used to prevent cardiovascular disease, it will be apparent that there is going to be relatively high use of these agents in the men who are also at some degree of risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: aspirin, NSAID, Prevention, PSA level, volume | Leave a comment »
On October 31st we reported that statins lower PSA levels. Now comes evidence that aspirin and other NSAIDs also lower PSA levels, in both patients with prostate cancer and in men with no prostate cancer diagnosis. … READ MORE …
Filed under: Diagnosis, Prevention, Treatment | Tagged: aspirin, NSAID, Prevention | Leave a comment »
Today’s news items are focused on issues affecting risk for prostate cancer and risk for progression after treatment, and the ways these risks can be affected by available data:
Filed under: Diagnosis, Management, Prevention, Treatment | Tagged: downgrading, Gleason, NSAID, pathological, risk, score, upgrading | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 